Activest Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.3K Buy
282
+5
+2% +$416 ﹤0.01% 399
2026
Q2
$18.7K Buy
277
+97
+54% +$6.46K ﹤0.01% 460
2026
Q1
$11.3K Sell
180
-35
-16% -$2.44K ﹤0.01% 657
2025
Q4
$14.3K Buy
215
+195
+975% +$12.6K ﹤0.01% 583
2025
Q3
$1.35K Sell
20
-20
-50% -$1.58K ﹤0.01% 837
2025
Q2
$3.49K Sell
40
-26
-39% -$2.04K ﹤0.01% 605
2025
Q1
$4.51K Buy
66
+63
+2,100% +$5.14K ﹤0.01% 526
2024
Q4
$233 Buy
+3
New +$222 ﹤0.01% 625

Other funds holding DXCM

Activest Wealth Management's DXCM Position: Q3 2026 in Review

Activest Wealth Management increased its DexCom (DXCM) stake by 1.8% in Q3 2026, buying an estimated $416 and bringing the position to 282 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #399.

Activest Wealth Management first reported a position in DXCM in Q4 2024 and has held it in 8 quarters since. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Activest Wealth Management held 282 shares of DexCom worth $24.3K as of Q3 2026.
  • Activest Wealth Management bought 5 DexCom shares in Q3 2026, an estimated $416.
  • DexCom made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #399 holding.
  • Activest Wealth Management first reported a position in DexCom in Q4 2024 and has held it in 8 quarters since.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.